Learn how GPT-5 Lobster and Claude Code are reshaping innovation with advanced features for coding, automation, and creative possibilities.

For now, Microsoft is marking the Copilot Mode as ‘experimental’, and is unlocking this functionality for free for users who ...

Julius AI, a startup that describes itself as an AI data analyst, announced it has raised a $10 million seed round led by ...

As it prepares to celebrate a decade as the UK’s biggest event for the built environment, UK Construction Week (UKCW) has ...

A new study found AI chatbots often suggest significantly lower salaries to women and minorities The research showed that identity cues can trigger consistent biases in salary negotiation advice The ...

While the West buzzes with the rise of OpenAI’s GPT-4.5 and xAI’s Grok-4, a powerful open-source challenger has emerged in ...

“The future of hiring lies in identifying deep tech talent early, investing in skill development, and being agile in ...

The company trained GLM-4.5 through a multistep workflow. First, it developed an initial version of the model using a dataset ...

OpenAI’s ChatGPT accounted for over 80% of total AI-driven referrals in June 2025. The data covers traffic from AI chatbot ...

Everyone's talking about JSON prompting like it's the next big thing in AI. Look, here's the deal. Just like every other ...

Discover how Agent Swarm 2.0 and AI sub-agents are automating 90% of coding tasks, transforming workflows, and redefining software development.

The advent of artificial intelligence (AI) at the US Food and Drug Administration (FDA) is changing the complexion of the regulatory approval process for medical devices.